Biomarker Development Framework
13 Questions
0 Views

Biomarker Development Framework

Created by
@AuthenticLynx

Questions and Answers

What is the primary advantage of the Oncotype Dx breast cancer test?

  • It provides a personalized prediction of breast cancer relapse risk. (correct)
  • It eliminates the need for surgery in all patients.
  • It guarantees a cure for breast cancer.
  • It predicts the exact time of cancer relapse.
  • Which biomarkers are mentioned as important for individualized treatment decisions in acute myeloid leukemia?

  • HER2 and estrogen receptors
  • FLT3 and nucleophosmin (NPM1) mutations (correct)
  • p53 and RAS mutations
  • BRCA1 and BRCA2 mutations
  • What technological approach is being escalated to replace single biomarker testing?

  • Gene chips and microarray technology (correct)
  • Biopsy and histopathology
  • Nanotechnology and drug delivery systems
  • Traditional blood tests and imaging
  • What is the purpose of immunophenotyping by flow cytometry?

    <p>To diagnose hematological malignancies and monitor residual diseases</p> Signup and view all the answers

    How does the Oncotype Dx breast cancer test potentially impact chemotherapy treatment decisions?

    <p>It helps avoid unnecessary chemotherapy by assessing relapse risk.</p> Signup and view all the answers

    What is one characteristic that an ideal biomarker should possess?

    <p>It should be specific and sensitive.</p> Signup and view all the answers

    Which of the following is an application of biomarkers in medical practice?

    <p>Immunophenotyping for diagnosing hematological malignancies.</p> Signup and view all the answers

    During the discovery process, what is the purpose of qualifying biomarkers in samples?

    <p>To gain confidence in their clinical utility.</p> Signup and view all the answers

    Which of the following biomarker types is NOT mentioned as a discovery matrix?

    <p>Hair samples</p> Signup and view all the answers

    In what manner should an ideal biomarker be cost-effective?

    <p>It should provide affordable follow-up monitoring.</p> Signup and view all the answers

    Which regulatory agencies have formal approval procedures for companion diagnostics?

    <p>European Medicines Agency and FDA.</p> Signup and view all the answers

    What is the significance of FLT3 and nucleophosmin (NPM1) mutations in acute myeloid leukemia?

    <p>They play important roles in individualizing treatment decisions.</p> Signup and view all the answers

    Which biofluid is commonly used for discovery in the context of biomarkers?

    <p>Tissue extracts</p> Signup and view all the answers

    Study Notes

    Development of Biomarkers

    • Biomarkers can be discovered using various tissue extracts or biological fluids such as urine, synovial fluid, cerebral fluid, blood, saliva, and tissue samples.
    • Biomarker qualifying processes, in both in vitro and in vivo studies, provide confidence in clinical utility for potential biomarkers.
    • Formal approval processes by the European Medicines Agency and FDA are essential for qualifying companion diagnostics or techniques linked to therapeutic drug development.
    • The effective use of biomarkers in treatment reduces unnecessary therapies, mitigates toxicities, and lowers overall healthcare costs.

    Ideal Characteristics of Biomarkers

    • Reliability is essential for consistent results.
    • Biomarkers should be safe, easy to measure, sensitive, and specific for accurate results.
    • The ability to modify with treatment ensures relevance over time.
    • Cost efficiency is crucial for follow-ups to promote sustainable healthcare.
    • Applicable in diagnosis, staging, and prognosis of diseases.

    Applications of Novel Biomarkers

    • Immunophenotyping via flow cytometry is critical for diagnosing hematological malignancies and monitoring minimal residual diseases.
    • Immunohistostaining techniques help identify specific cancer types through molecular markers.
    • FLT3 and nucleophosmin (NPM1) mutations play significant roles in tailoring treatment for acute myeloid leukemia.
    • Gene chips and microarray technologies allow simultaneous assessment of multiple molecular markers, moving towards standardizing clinical practices over single biomarker tests.
    • Oncotype Dx, a 21-gene panel assay, predicts the risk of breast cancer relapse, potentially decreasing the need for unnecessary adjuvant chemotherapy.

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Description

    Explore the framework for identifying potential biomarkers using various biological fluids and tissue extracts. This quiz covers the discovery process and the significance of qualifying biomarkers in clinical applications. Understand how different biofluids serve as matrices for potential biomarkers.

    More Quizzes Like This

    Biomarkers and Translational Research Quiz
    15 questions
    Biomarkers Classification Quiz
    30 questions

    Biomarkers Classification Quiz

    WellEstablishedSugilite2545 avatar
    WellEstablishedSugilite2545
    Biomarkers for Acute Kidney Injury
    10 questions
    Use Quizgecko on...
    Browser
    Browser